Astellas Pharma Inc., a pharmaceutical company operating in more than 70 countries worldwide, announced a strategic partnership with Mass General Brigham, focused on translational medicine and early-stage development, to create an integrated approach
In the pre-election budget, which did not mention any changes in direct or indirect taxes, Union Finance Minister Nirmala Seetharaman announced new plans to promote bio-based manufacturing in biomedicine and plans to set up more medical colleges.
Astellas Pharma Canada, Inc., the Canadian subsidiary of Astellas Pharma Inc. of Tokyo, announced that Health Canada has approved a new drug application for Xtandi (enzalutamide) in the advanced treatment area of prostate cancer.
.jpg)
Stryker, one of the world’s leading medical technologies companies, has introduced the Tornier shoulder arthroplasty portfolio in India and launched its first new Tornier product, the PerformTM Humeral Stem today at Shoulder Conclave in Pune...
Cancer vaccines will become more expensive after the government considers adding the human papillomavirus (HPV) vaccine to the national immunization program
Piramal Pharma Ltd detailed a 14% year-on-year ascend in its united income from tasks to ₹1,959 crore in the December finished quarter (Q3FY24), driven areas of strength for by across its verticals.
Glenmark said it has collaborated with Pfizer to send off abrocitinib in India utilized for treatment of moderate-to-extreme atopic dermatitis (Promotion). Glenmark and Pfizer will co-market abrocitinib in India under the brand names JABRYUS and...
QIAGEN has launched two disease test panels for its QIAstat-Dx device in India, including the gastrointestinal panel two and meningitis/encephalitis panel
Fresenius Kabi is posaconazole, an alternative to Noxafil, which treats or prevents severe fungal infections in adults and children at risk of developing fungal infections due to a weakened immune system.
Glenmark Pharmaceuticals Ltd. (Glenmark), a research-focused global pharmaceutical company, and Ichnos Sciences Inc. (Ichnos), an international clinical technology subsidiary, announced the launch of its partnership, Ichnos Glenmark Innovation.
, CDSCO.jpg)
